| pubmed-article:21631324 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0021756 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0281722 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C1420066 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:21631324 | lifeskim:mentions | umls-concept:C0599934 | lld:lifeskim |
| pubmed-article:21631324 | pubmed:issue | 22 | lld:pubmed |
| pubmed-article:21631324 | pubmed:dateCreated | 2011-6-2 | lld:pubmed |
| pubmed-article:21631324 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:abstractText | Stimulating an immune response against cancer with the use of vaccines remains a challenge. We hypothesized that combining a melanoma vaccine with interleukin-2, an immune activating agent, could improve outcomes. In a previous phase 2 study, patients with metastatic melanoma receiving high-dose interleukin-2 plus the gp100:209-217(210M) peptide vaccine had a higher rate of response than the rate that is expected among patients who are treated with interleukin-2 alone. | lld:pubmed |
| pubmed-article:21631324 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21631324 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21631324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21631324 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21631324 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21631324 | pubmed:issn | 1533-4406 | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:HwuPatrickP | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:MarincolaFran... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:ReintgenDougl... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:GonzalezReneR | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:Schwartzentru... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:RosenbergStev... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:ChoykePeterP | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:MerinoMaria... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:MillerDonald... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:ConlonKevinK | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:LawsonDavid... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:PockajBarbara... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:KuzelTimothy... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:RileyLeeL | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:KaufmanHoward... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:ConryRobert... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:WhiteRichard... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:WhitmanEric... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:BalkissoonJai... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:GailaniFawazF | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:VenaDonD | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:RichardsJon... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:CurtiBrendanB | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:KendraKari... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:TreismanJonat... | lld:pubmed |
| pubmed-article:21631324 | pubmed:author | pubmed-author:LemingPhillip... | lld:pubmed |
| pubmed-article:21631324 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21631324 | pubmed:day | 2 | lld:pubmed |
| pubmed-article:21631324 | pubmed:volume | 364 | lld:pubmed |
| pubmed-article:21631324 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21631324 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21631324 | pubmed:pagination | 2119-27 | lld:pubmed |
| pubmed-article:21631324 | pubmed:dateRevised | 2011-8-26 | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:meshHeading | pubmed-meshheading:21631324... | lld:pubmed |
| pubmed-article:21631324 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21631324 | pubmed:articleTitle | gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. | lld:pubmed |
| pubmed-article:21631324 | pubmed:affiliation | Indiana University Health Goshen Center for Cancer Care, Goshen, IN 46526, USA. dschwart@iuhealth.org | lld:pubmed |
| pubmed-article:21631324 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21631324 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21631324 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21631324 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| pubmed-article:21631324 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21631324 | lld:pubmed |
